Corgenix to Release Fiscal 2007 First Quarter Results and Host Conference Call on November 14, 2006.

DENVER -- Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Tuesday, November 14, 2006 at 5:00 PM EST (3:00 PM MST) to discuss the Company's financial and operating performance for its first fiscal quarter of 2007, as well as the status of the Company's product development and marketing activities.

Corgenix invites all those interested in hearing management's discussion of first quarter results to join the call by dialing 877-407-8033. International participants may access the call by dialing 201-689-8033. A replay will be available for one week following the call by dialing 877-660-6853 for domestic participants and 201-612-7415 for international participants and entering account number 286 and conference ID number 218123 when prompted. Participants may also access a live webcast of the conference call through the investor relations section of Corgenix's website, www.corgenix.com.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at www.corgenix.com.